Pancreatic Cancer Research

ResearcherKagoshima UniversityNo recent work listed

Sonshin Takao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113604948. Sources: OpenAlex.

Their work

Papers
22 (first author 3, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2011: 2 papers · 2012: 8 papers · 2013: 3 papers · 2014: 2 papers · 2015: 4 papers · 2016: 3 papers

Papers 22

  1. miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. Last author DOI 10.1007/s13577-016-0137-7↗
  2. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition. Last author DOI 10.1186/s12943-016-0534-2↗
  3. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Last author DOI 10.3390/ijms17071025↗
  4. Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells. Last author DOI 10.1007/s13577-015-0117-3↗
  5. Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Co-author DOI 10.1016/j.pan.2015.09.015↗
  6. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates gr… Co-author DOI 10.1080/15384047.2014.1002357↗
  7. Assessment of percutaneous laparoscopic ultrasonography-guided core needle biopsy for the advanced diagnosis of unresectable pancreatic cancer. Co-author DOI 10.6092/1590-8577/2891↗
  8. Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study. Last author DOI 10.1002/jhbp.6↗
  9. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Last author DOI 10.1186/1476-4598-13-15↗
  10. mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions. Last author DOI 10.1038/srep03230↗
  11. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pa… First author DOI 10.1097/mpa.0b013e318254f2d1↗
  12. [Examination of resectable and borderline pancreatic cancer treated with neoadjuvant chemoradiation therapy]. Co-author PMID 24393873↗
  13. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. First author DOI 10.1002/jso.23020↗
  14. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer. Last author DOI 10.1007/s00534-011-0400-y↗
  15. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy. Co-author DOI 10.1007/s00534-012-0547-1↗
  16. Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic c… Last author DOI 10.1007/s13577-011-0037-9↗
  17. Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. Last author DOI 10.1111/j.1349-7006.2012.02235.x↗
  18. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer. First author DOI 10.1245/s10434-012-2263-0↗
  19. Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0044108↗
  20. [A case of pancreatic cancer with liver metastasis controlled effectively by chemotherapy based on chemosensitivity test and stereotactic body radiotherapy]. Co-author PMID 22421785↗
  21. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. Last author DOI 10.1016/j.jss.2009.05.026↗
  22. Advanced staging laparoscopy using single-incision approach for unresectable pancreatic cancer. Co-author DOI 10.1097/sle.0b013e31823bae57↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiang Ding · 12 shared papers, 2012–2016 · strength 0.56
  2. Shoji Natsugoe · 15 shared papers, 2011–2016 · strength 0.56
  3. Yumi Miyazaki · 8 shared papers, 2012–2016 · strength 0.41
  4. Yuko Mataki · 11 shared papers, 2011–2015 · strength 0.37
  5. Koichiro Tsukasa · 6 shared papers, 2013–2016 · strength 0.35
  6. Kosei Maemura · 10 shared papers, 2011–2015 · strength 0.34
  7. Shyuichiro Matsubara · 7 shared papers, 2012–2016 · strength 0.34
  8. Hiroshi Kurahara · 10 shared papers, 2011–2015 · strength 0.33
  9. Koki Maeda · 6 shared papers, 2012–2016 · strength 0.21
  10. Hiroyuki Shinchi · 5 shared papers, 2012–2016 · strength 0.18
  11. Tomomi Hayashi · 4 shared papers, 2011–2016 · strength 0.14
  12. Michiyo Higashi · 2 shared papers, 2012–2013 · strength 0.07
  13. Masaaki Oka · 1 shared paper, 2015 · strength 0.05
  14. Susumu Ishiguro · 1 shared paper, 2015 · strength 0.05
  15. Ryouichi Tsunedomi · 1 shared paper, 2015 · strength 0.05
  16. Masaaki Tamura · 1 shared paper, 2015 · strength 0.05
  17. Yoichiro Matsuo · 1 shared paper, 2014 · strength 0.04
  18. Suguru Yonezawa · 1 shared paper, 2012 · strength 0.03
  19. Sho Kitamoto · 1 shared paper, 2012 · strength 0.03
  20. Seiya Yokoyama · 1 shared paper, 2012 · strength 0.03
  21. Surinder K. Batra · 1 shared paper, 2012 · strength 0.03
  22. Masayuki Nakajo · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.